🔎 Trials Near Me

Home › Polycythemia Vera

Polycythemia Vera clinical trials recruiting in the U.S.

16 studies for Polycythemia Vera are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06661915

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07469891

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT04282187

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07429266

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694

Registry of Older Patients With Cancer

RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 2, 2026 · NCT06351631

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 25, 2026 · NCT06093672

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 10, 2026 · NCT05123365

Ruxolitinib in Thrombocythemia and Polycythemia Vera

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 8, 2026 · NCT04644211

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT06541249

Two Step Haplo With Radiation Conditioning

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 30, 2025 · NCT05031897

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 27, 2025 · NCT01137643

Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition

RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 3, 2024 · NCT06218628

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.